Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Medical Research Society studies mggest that additional genetic factors are actiog to produce the disease phenotype. We have show that the HLA alleles and CD do not cc-segregate in families multipb al€& with CD.Suggesting that the HLA association is entirely due to the necessity to have these DQ alleles in orda to eapress CD, but that the main genet;c&kpcsitia~k atalmsotherthao theMHC. We hypouKsisedthat some of the insulin depeoacnt diabeta mllitus (lDDh4) susceptibility loci d d be common to CD since CD is fwod in loo/. of IDDM patienls. In order to test this hypourdslwenty-fiveEuropean two- or three-generation,multiply affectedfamilies were shdied using fluoresccntly labelled microsatellite markas linked to theloci Mplicptedin D D M These miuosatellitawere analysed using an ABI fluorrscent DNAsquartr. subdinicslCD was identified in the familiesusing anti-endomysial g with Qodcnalbiopsy of positive cases HLA typing of the DQ antibody d lod was performedby PCR and stquenocspeciIic oligonucleotide hybridization In tbc~~8nalysisDQ2acgafivesubjectswactrratalashavingunlmown~ection status. This p m t s any of carriers of the CD gene who do not have the HLA swxpliiilityallelesiiun beinga-nmled as ncombinaots thus redXingthepossibility ofafalseacgativedt Ldsooreanalysiswapperfdusingh4LINK,assumiog dominanttrananisSmwithWhpeaehaaceaadagene~ofO.O1. ModeliitewalysiPwPspwing~wiichrepwtsa~1-6eelodsmeand themaximumkd soac obtained f a any h.aasmissioamodel. We have examined the ~D6S264.D6S273.D6S290.D6S291.D8S88.D8S257.D8S556.D10S197. DlOSUo.D1 lS922,D13S122. D13S158. D I W , ESR and TH, which have been implicated m the genet;c aetiology of D D M by Davis et al(1994). and have found no evidence to mggcst that any of these loci are linkedwith susceptibility to CD. M58 EFFECT OF INSULIN ON THE PZ-ADRENOCEPTORMEDIATEDCAMPRESPONSE INBC3HI CELLS HE HOPKINSONand SJ HILL 17~ or supranormal urinary outputs o f calcium, although the mean plasma 1.25(OH)zD level of the subnormal group is lower than in the others combined (Hine TJ et al Clin Sci 74 Suppl IS, 741, 19SS). Patients in the latter two groups (5 male, 15 female; age 23-83 yr; 6 supranormal) have therefore been studied by six-day balances. Calcium intake (1 1.9-59.4 inmollday) was that normally ingested, as assessed by a metabolic dietitian. Patients were not taking vitamin D, fluoride, corticoids or diuretics. Nine were in neutral balance(tlO% intake) 7 positive and 4 negative. Urinary calcium output (2,s-9.55 mmol/day) was significantly negatively correlated with plasma 1,25(OH)2D (41-197 pmol/L) in the combined groups, r = -0.494. p<0.05; in a subnormal group the reverse is known to occur (Hine TJ et al Clin Sci 86 Suppl 30, 24p 1994; r = + 0.607: pcO.001). Urinary calcium was.positively correlated r = +0.723. p<O.Ol. with plasma 25OHD ( 1 5 4 7 nmol/L) in the normal group. negatively with the plasma 1.25(OH)zD/PTH ratio (0.74-4.03) in the combined groups (I= -0.566. pc0.02) and positively (r = +0.6lS.p<0.02) with net calcium absorption (9.7-42.7% of intake) in the normal group. Urinary calcium was not significantly correlated with calcium intake ( r = +0.237), urinary Na' (r = +O. 176). age (r = -0.3S7). plasma PTH (r = + 0.409) or balance (r = - 0.274) in the combined (or either) groups. Two interesting, unexpected points emerge: plasma 25-OHD has a role in urinary calcium excretion in normocalciuric osteoporosis, and the role of plasma 1,2S(OH)zD in calcium excretion differs in patients with differing outputs o f calcium. Department o f Physiology and Pharmacology, University of Nottingham, NottinghamNG7 2UH, England Previous work using fractionated cell membrane preparations Gom transfected cell lines has suggested chat phosphorylation of the Pradmoceptor by the activated insulin receptor yosine k m c leads to an attenuation of isoprenaliistimulated daylyl cyclase activity (Karoor V et al, JBC 270(43):25305-25308). The present shdy employodh DC3Hl ccll lie which is established as a smooth muscle model and express awrogaxxlrbbotha hmaiaralinsulin receptor and a P,-adrenoceptor. In this communication we show that insulin produces an augmentation of the maximum isoprenalie-stimulated accumulation of cAhW in intact BC3Hl cells. M J H l cells were grown to confhnxr in 24 well plates and loaded with 'H-denim. Cells wue stimulatedwith isoprenaline for 1O'minuteswith or without pre-exposure to lOOnM soluble insulin (porcine Velosulm) for 30 minutes. Tritiated CAMPwas isohled tkm whole cell lysaks by sequential Dowex-Aluminn chromatography. The presence of functional insulin receptors was confmed using a3,H-2-deoxygluuKe w studies wcre uptake assay, and competitive whole cell insulin receptor b perfmed using 'BI-Iabelled porcine insulin. The EC, value for isoprenaline was 70 f Inh4 with maximal CM accumulation occmingat a concentration of IOpM. The specific ~a-amenoeeptOr antagonist ICI 118,551 caused potent inhibition of isopnnaline-stimulatedcAhW produaion (KD = 0.lnM). D a d 1 H - 2 d ~ x y guptake l ~ ~by ~ h e =HI cells was m d by 45% i 6% @< 0.01) in response to IOOnM insulin M a m a t of l'I-ins~li b eamlimedthe presena:ofbigh affmity binding sites (IC, 30 f 0.5pM). Pre m d o n o f B C 3 H l cellswith lOOnMinsulincauseda263%increasc(pc0.01) in the maximum isopdine-stimulated accumulation of cAhW, but there was no eKect of insulinon the EC,or slope of the isoprenalineQse rrspoase curve. This stuay demonsbates a small but significant potentiation of the isoprenali stimulated pa-admmccptor response by insdin, in intact cells with ecdogcnourly scpressedreceptors. These &conW i h prevlws reports in trwsfected cell membrane preparations, but are in keeping with data from pemcabilized human lymphoqtes(FeldmanRD,BJP 110:164M644 1993). Cross-talkbdweentyrosine kreceptors and 0 proteibcoupled receptors is k c r e a s i d reoognisedas an important p b m e n o n , and insulin-mediated augmentation of the p2-admloccptm responrc in vivo could be implicated in the Link between insulin resistaace and essential hypertension. M59 VERTEBRAL OSTEOPOROSIS: FACTORS AFFECTINGW A R Y CALCIUM EXCRETION T J Hine (introduced), N B Roberts and W H Taylor Departmentso f Clinical Chemistry and Medical Microbiology. Royal Liverpool University Hospital. Liverpool L7 S X P . I t is unclear why, at presentation, osteoporok patients exhibit subnormal, nornial (2.5-6.25 minollday. female; 3.0-7.5, male) M60 TWO NEUROPEPTIDE Y (NPY) ANTISENSE PHOSPHODIESTER OLIGODEOXYNUCLEOTIDES ARE INEFFECTIVE IN INHIBITING NPY GENE EXPRESSION IN THE RAT HYPOTHALAMUS Simon Dryden, Lucy Pickavance, David Tidd', Gareth Williams Diabetes & Endocrinology Research Unit, Department of Medicine and 'School of Biological Sciences (Biochemistry), University of Liverpool, UK. Neuropeptide Y (NPY) is a potent appetite stimulant when injected into the hypothalamus, especially the paraventricular nucleus (PVN). The arcuate nucleus (ARC) is the main site of NPY synthesis, and there are NPY neurones projecting upwards to the PVN, the main site of NPY release. Antisense oligonucleotides appear to inhibit gene expression in vitm, and in some cases, in vivo. This study aimed to compare the effect of an NPY-specific antisense unmodified phosphodiester (D-ODN) and a similar antisense propylprotected phosphodiester (P-ODN) on food intake body weight and NPY gene expression. For both ODNs, adult male rats (n=8/group) had the antisense ODN (24 pg/day) infused via osmotic minipumps for 7 days into the 3rd ventricle. Control rats (n=8/group) had either saline or a missense ODN (24 pg/day) infused under similar conditions. The rats were sacrificed after 7 days and NPY mRNA levels measured by Northern blotting. There were no significant changes in food intake, body weight or NPY mRNA levels in the antisense D-ODN-treated group compared with either of the control groups. Food intake and body weight were reduced by 9% and 6% respectively (p<0.05) in the antisense P-ODN-treated group compared with the saline-treated controls. NPY mRNA levels were unchanged in both the antisense and missense groups compared with the controls. These results suggest that these phosphodiester ODNs may not be effective in influencing their target mRNA, and therefore exerting a specific effect on hypothalamic NPY in the rat.